French scientists find new blood type in Guadeloupe woman
A French woman from the Caribbean island of Guadeloupe has been identified as the only known carrier of a new blood type, dubbed 'Gwada negative,' France's blood supply agency has announced.
The announcement was made 15 years after researchers received a blood sample from a patient who was undergoing routine tests ahead of surgery, the French Blood Establishment (EFS) said on Friday.
'The EFS has just discovered the 48th blood group system in the world!' the agency said in a statement on social network LinkedIn.
'This discovery was officially recognised in early June in Milan by the International Society of Blood Transfusion (ISBT).'
The scientific association had until now recognised 47 blood group systems.
READ | Current gonorrhoea meds might stop working. When will newer ones make it to SA?
Thierry Peyrard, a medical biologist at the EFS involved in the discovery, told AFP that a 'very unusual' antibody was first found in the patient in 2011. However, resources at the time did not allow for further research, he added.
Scientists were finally able to unravel the mystery in 2019 thanks to 'high-throughput DNA sequencing', which highlighted a genetic mutation, Peyrard said.
The patient, who was 54 at the time and lived in Paris, was undergoing routine tests before surgery when the unknown antibody was detected, Peyrard said.
This woman 'is undoubtedly the only known case in the world,' said the expert.
He said:
She is the only person in the world who is compatible with herself.
Peyrard said the woman inherited the blood type from her father and mother, who each had the mutated gene.
The name 'Gwada negative', which refers to the patient's origins and 'sounds good in all languages', has been popular with the experts, said Peyrard.
The ABO blood group system was first discovered in the early 1900s. Thanks to DNA sequencing, the discovery of new blood groups has accelerated in recent years.
Peyrard and colleagues are now hoping to find other people with the same blood group.
'Discovering new blood groups means offering patients with rare blood types a better level of care,' the EFS said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Cannabis Linked to 2x Risk of Heart Disease Death, Scientists Discover
New research suggests that cannabis use is linked to twice the risk of death from cardiovascular disease, and is also associated with increased risk of other major adverse cardiovascular events (MACE). Cannabis is being legalized in more and more places worldwide, increasing medicinal and recreational use – but it may warrant closer monitoring by health professionals. The researchers here, led by a team from the University of Toulouse in France, wanted to look more closely at potential health risks that had previously been flagged. They looked at 24 previous studies published between 2016 and 2023, involving around 200 million people. Overall, the increased risk linked to cannabis use was 29 percent for acute coronary syndrome (reduced blood flow to the heart), 20 percent for strokes, and 100 percent for cardiovascular disease mortality. "The findings reveal positive associations between cannabis use and MACE," write the researchers in their published paper. "These findings should encourage investigating cannabis use in all patients presenting with serious cardiovascular disorders." There are some limitations worth bearing in mind here. The studies included in the research differed in terms of how they defined cannabis use, relied on self-reporting, and didn't measure use of the drug over time. That makes them less statistically robust. The research also notes a high risk of bias in the majority of studies investigated, due to the way they were structured. And it's important to say the research doesn't show direct cause and effect, only an association. It's possible that other factors not considered here are driving both cannabis use and heart health issues in certain groups of people. Nevertheless, the large number of people surveyed on their real-world use of cannabis counts in the study's favor. It also has more recent data than many other studies, and we know that cannabis use and composition is changing over time. That's enough to warrant deeper investigation into the possible health risks. "Legalizing the drug and expanding its medical use worldwide have likely contributed to profound changes in the general perception of cannabis and to the overall rise in cannabis consumption," write the researchers. "Consequently, users' profiles and consumption habits profoundly differ from those in the 2010s, especially as cannabis products show an increasing trend in potency, with rising concentrations of delta-9-tetrahydrocannabinol (THC)." Further research is absolutely needed here, not least to determine whether the chemicals and compounds in cannabis – of which there are hundreds – could be leading to these health risks, and how taking cannabis in different forms, such as inhalables or edibles, might have an influence. Previous studies have already shown how the drug can increase the risk of cancer, and significantly alter our DNA, for example. Cannabis could also trigger psychosis through the impact it has on the brain. The new study is accompanied by an editorial written by epidemiologists Stanton Glanz and Lynn Silver, from the University of California San Francisco. In it, Glanz and Silver argue that as cannabis use rises, more should be done to educate people about the risks – as has been done with cigarettes. "Specifically, cannabis should be treated like tobacco: not criminalized but discouraged, with protection of bystanders from secondhand exposure," they write. The research has been published in the journal Heart. 5 Daily Habits Could Be Causing Your Liver Serious Harm FDA-Approved Sleeping Pill Slows Alzheimer's Tangles in Pre-Clinical Trial Risk of Sleep Breathing Disorder Set to Rise 45% by End of Century
Yahoo
9 hours ago
- Yahoo
Write, submit an idea, learn: Don't wait or hold back, just do it
We often imagine that the people who achieve great things in life – whether in science, art, or any field of impact – do so only when everything is in place. When they feel ready. When they have the resources. When confidence arrives like a green light. But that's rarely the case. If you wait until you feel fully skilled, fully prepared, fully sure – you'll be waiting forever. Because readiness isn't a moment that arrives before action. It's something that is built through action. The truth is, nobody has it all figured out from the start. Not even the ones who changed the world. Take Marie Curie. When she first began her groundbreaking research on radioactivity, she worked in what could barely be called a laboratory – just a leaky, unheated shed behind a school in Paris. Her equipment was rudimentary, her working conditions far from ideal. But she started anyway. Slowly, painstakingly, she uncovered the elements polonium and radium, and changed the course of science forever. She didn't wait to be invited into the halls of recognition. She walked in with curiosity and courage, even when everything around her said, not yet. Or consider Paul Lauterbur and Peter Mansfield, awarded the 2003 Nobel Prize in Physiology or Medicine for their work on magnetic resonance imaging (MRI). When Lauterbur first proposed his idea of spatial encoding of MRI signals – basically tracking movements of water molecules in our body under changing magnetic fields – he was told by several peers that the concept wouldn't work. His initial paper was even rejected by academic journals. But he didn't stop. He kept refining, experimenting, pushing forward. Peter Mansfield, working independently in the UK, added mathematical precision and practical applications to Lauterbur's vision. Together, through trial, failure, and persistence – not certainty – they helped create a medical breakthrough that has saved millions of lives. No one handed them a perfect roadmap. They began with what they had and allowed the process to show them the rest. The same is true of the Wright brothers. Neither Wilbur nor Orville had formal engineering training. They were bicycle mechanics with an obsession for flight. When they began designing their first aircraft, they had no guarantees. What they did have was a workshop, a windy field, and an unshakable willingness to try. And fail. And try again. On Dec 17, 1903, after years of trial and error, they achieved powered flight. What united these individuals wasn't certainty – it was movement. Because progress doesn't come from waiting for the perfect moment. It comes from doing what you can with what you have. From taking the first step, even when the second is unclear. That's where clarity comes from. That's where confidence begins – not before action, but after you begin. But too often, we let hesitation wear the mask of wisdom. We say we're preparing. Planning. Waiting for 'the right time.' But behind that delay often lives fear. Fear of getting it wrong. Fear of judgment. Fear of being seen before we feel complete. Yet what's worse than failing is never starting at all. Perfection is a seductive illusion. It convinces us that we need one more certificate, one more tool, one more dose of courage before we begin. But all perfection really does is delay progress. Because messy beginnings still move you forward. The first draft is always rough. The early stages of anything – be it a project, a paper, a plan – are supposed to feel shaky. That's not failure. That's momentum. Even in technology and research, we rarely launch with a finished product. Software goes live in beta. Hypotheses evolve mid-experiment. Scientific understanding is always, by nature, iterative. So why should we expect our personal or creative pursuits to be perfectly formed from the outset? Start before you feel ready. That's not recklessness. It's wisdom wrapped in action. Because here's the truth: you cannot think your way into certainty. But you can act your way into it. Each step you take reveals the next. Each small effort sharpens your direction. And over time, the fear that once held you back gets replaced by something far more valuable: belief in your ability to adapt. So if you've been holding back – waiting to feel smarter, braver, richer, more experienced – consider this your permission to begin. With shaky hands. With limited resources. With uncertainty still in the air. Start writing the thing. Submit the idea. Try the method. Take the class. Launch the version you have now. Imperfect action beats perfect procrastination every single time. Just stop waiting. The views expressed here are the personal opinion of the writer and do not necessarily represent that of Twentytwo13.
Newsweek
18 hours ago
- Newsweek
French Scientists Discover New Blood Group
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A group of French researchers have discovered a new, "ultra rare" blood group in a Guadeloupean woman after years of researching and sequencing her blood, the French Blood Establishment (EFS) said in a Friday press release. Newsweek has reached out to EFS's press team for comment via email on Saturday. Why It Matters The discovery marks the 48th known blood group system in the world. Understanding blood types is critical for ensuring safe and effective transfusions and organ transplants, as well as identifying certain health risks. Blood classification helps medical providers determine compatibility—or lack thereof—between donors and recipients. There are approximately 14 million units of blood transfused annually in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC). Outside of the well-known ABO system, there are a series of rare blood groups. What To Know In a social media post on LinkedIn, the EFS said in French that "this discovery was officially recognized in early June in Milan by the International Society of Blood Transfusion (ISBT)." The woman is the only known carrier of a rare blood type called "Gwada negative." The case first drew attention in 2011 when she required a blood transfusion, but no compatible donor could be found. Researchers later revisited her case in 2019 and identified the unique blood type through further analysis, according to the EFS's Friday press release. Thierry Peyrard, a medical biologist at the EFS involved in the discovery, told Agence France-Presse (AFP) that a "very unusual" antibody was found in the patient's blood in 2011. She was 54 years old at the time when she underwent a series of tests prior to surgery, according to Le Monde. Due to limited resources at the time, research into her blood type had been halted. Peyrard said the woman inherited the blood type from her parents who had the mutated gene. EFS, in French, said that the discovery "brings hope to patients, especially those with a rare blood type. Remember that the safety of a transfusion depends on the compatibility of blood groups." The group says it has been responsible for identifying 10 of the past 17 blood group systems discovered in the past decade. Karl Landsteiner discovered the first blood groups in the early 1900s and was awarded the Nobel Prize in 1930 for his work. Serum tubes with blood samples from patients are processed in the central medical laboratory of the St. Georg Clinic in Leipzig. Serum tubes with blood samples from patients are processed in the central medical laboratory of the St. Georg Clinic in Leipzig. Waltraud Grubitzsch/picture-alliance/dpa/AP Images What People Are Saying The official Nobel Prize account posted on X, formerly Twitter, on June 17: "The discovery of blood groups completely changed the view on blood transfusions, and it didn't take long before the first successful attempts were carried out. During WWI, blood transfusions were first performed on a large scale. Countless lives were also saved through surgeries, which previously had been unfeasible due to the blood loss involved." What Happens Next? Scientists continue to study blood types, advancing global health care and improving the precision and effectiveness of transfusions.
